The effect of 3435C>T MDR1 gene polymorphism on rheumatoid arthritis treatment with disease-modifying antirheumatic drugs

Author： Drozdzik Marek Rudas Tomasz Pawlik Andrzej Kurzawski Mateusz Czerny Bogusław Gornik Wanda Herczynska Magdalena

Publisher： Springer Publishing Company

ISSN： 0031-6970

Source： European Journal of Clinical Pharmacology, Vol.62, Iss.11, 2006-11, pp. : 933-937

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pharmacokinetics of tramadol is affected by MDR1 polymorphism C3435T

By Slanař Ondřej Nobilis Milan Kvétina Jaroslav Matoušková Olga Idle Jeffrey Perlík František

European Journal of Clinical Pharmacology, Vol. 63, Iss. 4, 2007-04 ,pp. : 419-421

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine

By Umićević Mirkov Maša Coenen Marieke JH

Pharmacogenomics, Vol. 14, Iss. 4, 2013-03 ,pp. : 425-444

Future Medicine

Access to resources Recommend Favorite

Efficacy, Tolerability and Cost Effectiveness of Disease-Modifying Antirheumatic Drugs and Biologic Agents in Rheumatoid Arthritis

By Nurmohamed Michael T. Dijkmans Ben A.C.

Drugs, Vol. 65, Iss. 5, 2005-01 ,pp. : 661-694

Adis International

Access to resources Recommend Favorite

Guidelines for the Use of Conventional and Newer Disease-Modifying Antirheumatic Drugs in Elderly Patients with Rheumatoid Arthritis

By Díaz-Borjón Alejandro

Drugs & Aging, Vol. 26, Iss. 4, 2009-05 ,pp. : 273-293

Adis International

Access to resources Recommend Favorite

The frequency of the C3435T MDR1 polymorphism is significantly lower in Ghanians

Inpharma, Vol. 1, Iss. 1300, 2001-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite